|
|
Article: PDI to handle U.S. commercialization of wound care products.
- Article from:
- Biotech Week
- Article date:
- January 1, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 JAN 1 - (NewsRx.com & NewsRx.net) -- PDI, Inc., (PDII) and Xylos Corp. announced that they have signed a 10-year agreement in which Xylos will retain PDI Medical Devices and Diagnostics to be the exclusive commercialization partner for the marketing, sales, and distribution of the Xylos' line of XCell Cellulose Wound Dressing wound care products.
As a complete commercialization partner, PDI taps into all areas of its infrastructure by providing Xylos with a focused sales team, medical education, marketing research, managed markets and trade relations, product identity and branding, product management, and clinical sales support through its PDI InServe ...